Portfolio

Kaia Health secures strategic investment to accelerate US growth

SEP 17, 2019

The digital therapeutics company secured $8M capital infusion, led by Optum Ventures, the independent venture fund of Optum, part of UnitedHealth Group.

The partnership will help Kaia Health to accelerate sales growth in the U.S. healthcare market, extend its platform into other chronic indications and expand the supporting clinical evidence base.

Kaia's exercise program was developed in collaboration with pain treatment experts and shows proven benefits in clinical trials.

Kaia Health has developed a smartphone-based approach for managing a range of chronic conditions, with its leading product focused on musculoskeletal disorders, such as chronic back pain.

Its motion tracking technology enables users to get real-time feedback on their exercise performance using their smartphone’s camera, which, when combined with the app’s psychological and education support, has been proven to outperform conventional therapy.

The company already has three peer-reviewed clinical studies, including a randomised controlled trial recently published in NPJ Digital Medicine, and has additional clinical studies ongoing in the United States.

Read more: 

Stay in touch with Balderton

Sign up for our newsletter to stay up to date on news from Balderton, and our portfolio.